BCG vaccination to reduce the impact of COVID-19 in healthcare workers

BCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging pathogens. As a readily available, inexpensive intervention that has a well-established safety profile, BCG is a good candidate for protecting healthcare workers (HCWs) and o...

Descripción completa

Detalles Bibliográficos
Autores: Pittet, Laure F.|||0000-0002-2395-4574, Messina, Nicole L.|||0000-0001-8404-4462, Gardiner, Kaya|||0000-0001-9796-4567, Orsini, Francesca, Abruzzo, Veronica, Bannister, Samantha|||0000-0001-7507-3704, Bonten, Marc, Campbell, John L.|||0000-0002-6752-3493, Croda, Julio, Dalcolmo, Margareth|||0000-0002-6820-1082, Elia, Sonja|||0000-0002-6368-189X, Germano, Susie|||0000-0001-9924-7545, Goodall, Casey, Gwee, Amanda|||0000-0003-4016-8986, Jamieson, Tenaya, Jardim, Bruno|||0000-0003-3465-7556, Kollmann, Tobias R.|||0000-0003-2403-9762, Guimarães Lacerda, Marcus Vinícius|||0000-0003-3374-9985, Lee, Katherine J.|||0000-0002-8334-0291, Legge, Donna, Lucas, Michaela|||0000-0001-8881-9990, Lynn, David J.|||0000-0003-4664-1404, McDonald, Ellie|||0000-0003-2295-4641, Manning, Laurens|||0000-0003-4334-5351, Munns, Craig F.|||0000-0001-5898-5808, Perrett, Kirsten P.|||0000-0002-5683-996X, Prat i Aymerich, Cristina|||0000-0001-6974-9165, Richmond, Peter|||0000-0001-7562-7228, Shann, Frank|||0000-0002-9899-1804, Sudbury, Eva, Villanueva, Paola|||0000-0002-6504-2979, Wood, Nicholas J., Lieschke, Katherine, Subbarao, Kanta|||0000-0003-1713-3056, Davidson, Andrew, Curtis, Nigel|||0000-0003-3446-4594
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:282522
Acceso en línea:https://ddd.uab.cat/record/282522
https://dx.doi.org/urn:doi:10.1136/bmjopen-2021-052101
Access Level:acceso abierto
Palabra clave:COVID-19
Immunology
Infectious diseases
Microbiology
Virology
id ES_12909ea3f4df8a52b3bfed47b92a92e1
oai_identifier_str oai:ddd.uab.cat:282522
network_acronym_str ES
network_name_str España
repository_id_str
spelling BCG vaccination to reduce the impact of COVID-19 in healthcare workersProtocol for a randomised controlled trial (BRACE trial)Pittet, Laure F.|||0000-0002-2395-4574Messina, Nicole L.|||0000-0001-8404-4462Gardiner, Kaya|||0000-0001-9796-4567Orsini, FrancescaAbruzzo, VeronicaBannister, Samantha|||0000-0001-7507-3704Bonten, MarcCampbell, John L.|||0000-0002-6752-3493Croda, JulioDalcolmo, Margareth|||0000-0002-6820-1082Elia, Sonja|||0000-0002-6368-189XGermano, Susie|||0000-0001-9924-7545Goodall, CaseyGwee, Amanda|||0000-0003-4016-8986Jamieson, TenayaJardim, Bruno|||0000-0003-3465-7556Kollmann, Tobias R.|||0000-0003-2403-9762Guimarães Lacerda, Marcus Vinícius|||0000-0003-3374-9985Lee, Katherine J.|||0000-0002-8334-0291Legge, DonnaLucas, Michaela|||0000-0001-8881-9990Lynn, David J.|||0000-0003-4664-1404McDonald, Ellie|||0000-0003-2295-4641Manning, Laurens|||0000-0003-4334-5351Munns, Craig F.|||0000-0001-5898-5808Perrett, Kirsten P.|||0000-0002-5683-996XPrat i Aymerich, Cristina|||0000-0001-6974-9165Richmond, Peter|||0000-0001-7562-7228Shann, Frank|||0000-0002-9899-1804Sudbury, EvaVillanueva, Paola|||0000-0002-6504-2979Wood, Nicholas J.Lieschke, KatherineSubbarao, Kanta|||0000-0003-1713-3056Davidson, AndrewCurtis, Nigel|||0000-0003-3446-4594COVID-19ImmunologyInfectious diseasesMicrobiologyVirologyBCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging pathogens. As a readily available, inexpensive intervention that has a well-established safety profile, BCG is a good candidate for protecting healthcare workers (HCWs) and other vulnerable groups against COVID-19. This international multicentre phase III randomised controlled trial aims to determine if BCG vaccination reduces the incidence of symptomatic and severe COVID-19 at 6 months (co-primary outcomes) compared with no BCG vaccination. We plan to randomise 10 078 HCWs from Australia, The Netherlands, Spain, the UK and Brazil in a 1:1 ratio to BCG vaccination or no BCG (control group). The participants will be followed for 1 year with questionnaires and collection of blood samples. For any episode of illness, clinical details will be collected daily, and the participant will be tested for SARS-CoV-2 infection. The secondary objectives are to determine if BCG vaccination reduces the rate, incidence, and severity of any febrile or respiratory illness (including SARS-CoV-2), as well as work absenteeism. The safety of BCG vaccination in HCWs will also be evaluated. Immunological analyses will assess changes in the immune system following vaccination, and identify factors associated with susceptibility to or protection against SARS-CoV-2 and other infections. Ethical and governance approval will be obtained from participating sites. Results will be published in peer-reviewed open-access journals. The final cleaned and locked database will be deposited in a data sharing repository archiving system. ClinicalTrials.gov.Universitat Autònoma de Barcelona 22021-01-0120212021-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/282522https://dx.doi.org/urn:doi:10.1136/bmjopen-2021-052101reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2825222026-06-06T12:50:31Z
dc.title.none.fl_str_mv BCG vaccination to reduce the impact of COVID-19 in healthcare workers
Protocol for a randomised controlled trial (BRACE trial)
title BCG vaccination to reduce the impact of COVID-19 in healthcare workers
spellingShingle BCG vaccination to reduce the impact of COVID-19 in healthcare workers
Pittet, Laure F.|||0000-0002-2395-4574
COVID-19
Immunology
Infectious diseases
Microbiology
Virology
title_short BCG vaccination to reduce the impact of COVID-19 in healthcare workers
title_full BCG vaccination to reduce the impact of COVID-19 in healthcare workers
title_fullStr BCG vaccination to reduce the impact of COVID-19 in healthcare workers
title_full_unstemmed BCG vaccination to reduce the impact of COVID-19 in healthcare workers
title_sort BCG vaccination to reduce the impact of COVID-19 in healthcare workers
dc.creator.none.fl_str_mv Pittet, Laure F.|||0000-0002-2395-4574
Messina, Nicole L.|||0000-0001-8404-4462
Gardiner, Kaya|||0000-0001-9796-4567
Orsini, Francesca
Abruzzo, Veronica
Bannister, Samantha|||0000-0001-7507-3704
Bonten, Marc
Campbell, John L.|||0000-0002-6752-3493
Croda, Julio
Dalcolmo, Margareth|||0000-0002-6820-1082
Elia, Sonja|||0000-0002-6368-189X
Germano, Susie|||0000-0001-9924-7545
Goodall, Casey
Gwee, Amanda|||0000-0003-4016-8986
Jamieson, Tenaya
Jardim, Bruno|||0000-0003-3465-7556
Kollmann, Tobias R.|||0000-0003-2403-9762
Guimarães Lacerda, Marcus Vinícius|||0000-0003-3374-9985
Lee, Katherine J.|||0000-0002-8334-0291
Legge, Donna
Lucas, Michaela|||0000-0001-8881-9990
Lynn, David J.|||0000-0003-4664-1404
McDonald, Ellie|||0000-0003-2295-4641
Manning, Laurens|||0000-0003-4334-5351
Munns, Craig F.|||0000-0001-5898-5808
Perrett, Kirsten P.|||0000-0002-5683-996X
Prat i Aymerich, Cristina|||0000-0001-6974-9165
Richmond, Peter|||0000-0001-7562-7228
Shann, Frank|||0000-0002-9899-1804
Sudbury, Eva
Villanueva, Paola|||0000-0002-6504-2979
Wood, Nicholas J.
Lieschke, Katherine
Subbarao, Kanta|||0000-0003-1713-3056
Davidson, Andrew
Curtis, Nigel|||0000-0003-3446-4594
author Pittet, Laure F.|||0000-0002-2395-4574
author_facet Pittet, Laure F.|||0000-0002-2395-4574
Messina, Nicole L.|||0000-0001-8404-4462
Gardiner, Kaya|||0000-0001-9796-4567
Orsini, Francesca
Abruzzo, Veronica
Bannister, Samantha|||0000-0001-7507-3704
Bonten, Marc
Campbell, John L.|||0000-0002-6752-3493
Croda, Julio
Dalcolmo, Margareth|||0000-0002-6820-1082
Elia, Sonja|||0000-0002-6368-189X
Germano, Susie|||0000-0001-9924-7545
Goodall, Casey
Gwee, Amanda|||0000-0003-4016-8986
Jamieson, Tenaya
Jardim, Bruno|||0000-0003-3465-7556
Kollmann, Tobias R.|||0000-0003-2403-9762
Guimarães Lacerda, Marcus Vinícius|||0000-0003-3374-9985
Lee, Katherine J.|||0000-0002-8334-0291
Legge, Donna
Lucas, Michaela|||0000-0001-8881-9990
Lynn, David J.|||0000-0003-4664-1404
McDonald, Ellie|||0000-0003-2295-4641
Manning, Laurens|||0000-0003-4334-5351
Munns, Craig F.|||0000-0001-5898-5808
Perrett, Kirsten P.|||0000-0002-5683-996X
Prat i Aymerich, Cristina|||0000-0001-6974-9165
Richmond, Peter|||0000-0001-7562-7228
Shann, Frank|||0000-0002-9899-1804
Sudbury, Eva
Villanueva, Paola|||0000-0002-6504-2979
Wood, Nicholas J.
Lieschke, Katherine
Subbarao, Kanta|||0000-0003-1713-3056
Davidson, Andrew
Curtis, Nigel|||0000-0003-3446-4594
author_role author
author2 Messina, Nicole L.|||0000-0001-8404-4462
Gardiner, Kaya|||0000-0001-9796-4567
Orsini, Francesca
Abruzzo, Veronica
Bannister, Samantha|||0000-0001-7507-3704
Bonten, Marc
Campbell, John L.|||0000-0002-6752-3493
Croda, Julio
Dalcolmo, Margareth|||0000-0002-6820-1082
Elia, Sonja|||0000-0002-6368-189X
Germano, Susie|||0000-0001-9924-7545
Goodall, Casey
Gwee, Amanda|||0000-0003-4016-8986
Jamieson, Tenaya
Jardim, Bruno|||0000-0003-3465-7556
Kollmann, Tobias R.|||0000-0003-2403-9762
Guimarães Lacerda, Marcus Vinícius|||0000-0003-3374-9985
Lee, Katherine J.|||0000-0002-8334-0291
Legge, Donna
Lucas, Michaela|||0000-0001-8881-9990
Lynn, David J.|||0000-0003-4664-1404
McDonald, Ellie|||0000-0003-2295-4641
Manning, Laurens|||0000-0003-4334-5351
Munns, Craig F.|||0000-0001-5898-5808
Perrett, Kirsten P.|||0000-0002-5683-996X
Prat i Aymerich, Cristina|||0000-0001-6974-9165
Richmond, Peter|||0000-0001-7562-7228
Shann, Frank|||0000-0002-9899-1804
Sudbury, Eva
Villanueva, Paola|||0000-0002-6504-2979
Wood, Nicholas J.
Lieschke, Katherine
Subbarao, Kanta|||0000-0003-1713-3056
Davidson, Andrew
Curtis, Nigel|||0000-0003-3446-4594
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv COVID-19
Immunology
Infectious diseases
Microbiology
Virology
topic COVID-19
Immunology
Infectious diseases
Microbiology
Virology
description BCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging pathogens. As a readily available, inexpensive intervention that has a well-established safety profile, BCG is a good candidate for protecting healthcare workers (HCWs) and other vulnerable groups against COVID-19. This international multicentre phase III randomised controlled trial aims to determine if BCG vaccination reduces the incidence of symptomatic and severe COVID-19 at 6 months (co-primary outcomes) compared with no BCG vaccination. We plan to randomise 10 078 HCWs from Australia, The Netherlands, Spain, the UK and Brazil in a 1:1 ratio to BCG vaccination or no BCG (control group). The participants will be followed for 1 year with questionnaires and collection of blood samples. For any episode of illness, clinical details will be collected daily, and the participant will be tested for SARS-CoV-2 infection. The secondary objectives are to determine if BCG vaccination reduces the rate, incidence, and severity of any febrile or respiratory illness (including SARS-CoV-2), as well as work absenteeism. The safety of BCG vaccination in HCWs will also be evaluated. Immunological analyses will assess changes in the immune system following vaccination, and identify factors associated with susceptibility to or protection against SARS-CoV-2 and other infections. Ethical and governance approval will be obtained from participating sites. Results will be published in peer-reviewed open-access journals. The final cleaned and locked database will be deposited in a data sharing repository archiving system. ClinicalTrials.gov.
publishDate 2021
dc.date.none.fl_str_mv 2
2021-01-01
2021
2021-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/282522
https://dx.doi.org/urn:doi:10.1136/bmjopen-2021-052101
url https://ddd.uab.cat/record/282522
https://dx.doi.org/urn:doi:10.1136/bmjopen-2021-052101
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403625748430848
score 15,300719